What is the address of MEDECINE DU SOMMEIL?

The registered office of MEDECINE DU SOMMEIL is located at Brugmannlaan 575, 1180 Ukkel.

Is MEDECINE DU SOMMEIL still active?

Not as usual. The CBE lists MEDECINE DU SOMMEIL with legal situation “Vrijwillige ontbinding – vereffening”.

Is MEDECINE DU SOMMEIL registered on Peppol?

No, MEDECINE DU SOMMEIL is currently not registered on the Peppol network.

What is the enterprise number of MEDECINE DU SOMMEIL?

The enterprise number of MEDECINE DU SOMMEIL is BE0471493244.

When was MEDECINE DU SOMMEIL founded?

MEDECINE DU SOMMEIL was founded on 23 March 2000.

Who are the directors of MEDECINE DU SOMMEIL?

According to the 2025 annual accounts, the directors of MEDECINE DU SOMMEIL are: Claude KATZ.

Is MEDECINE DU SOMMEIL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 23 March 2000; 6 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDECINE DU SOMMEIL make in 2025?

MEDECINE DU SOMMEIL posted a profit after taxes of € 83,892 in financial year 2025.

What is the revenue of MEDECINE DU SOMMEIL?

As a small company, MEDECINE DU SOMMEIL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 97,464.

MEDECINE DU SOMMEIL (Private Limited) - Ukkel

Dossier MEDECINE DU SOMMEIL, printed on 1 October 2026 from databakkes.be/en/0471493244/medecine-du-sommeil. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2025

MEDECINE DU SOMMEIL from Ukkel, company number BE0471493244, closed financial year 2025 with a result of € 83,892 after tax. For that financial year MEDECINE DU SOMMEIL recorded a gross margin of € 97,464 and equity of € 493,495. Compared with financial year 2024, the result moved from € -33,329 to € 83,892. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 13, 2026.

What it is worth Growing

€ 493,495

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 83,892

▲ still € 33,329 loss in 2024

Profit after tax over the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 473,495.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,952

▼ 34% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,389

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 13,051 Gross margin 2022: € 13,051 First fiscal year in the series	€ 6,790 Gross margin 2023: € 6,790 ▼ 48% vs 2022 (€ 13,051) Unfavourable step	€ -14,151 Gross margin 2024: € -14,151 ▼ € 20,941 vs 2023 (€ 6,790) Unfavourable step	€ 97,464 Gross margin 2025: € 97,464 ▲ € 111,615 vs 2024 (€ -14,151) Favourable step	▲ € 111,615
Profit after taxes	€ -19,447 Profit after taxes 2022: € -19,447 First fiscal year in the series	€ -12,296 Profit after taxes 2023: € -12,296 ▲ € 7,151 vs 2022 (€ -19,447) Favourable step	€ -33,329 Profit after taxes 2024: € -33,329 ▼ € 21,033 vs 2023 (€ -12,296) Unfavourable step	€ 83,892 Profit after taxes 2025: € 83,892 ▲ € 117,220 vs 2024 (€ -33,329) Favourable step	▲ € 117,220
Equity	€ 455,228 Equity 2022: € 455,228 First fiscal year in the series	€ 442,932 Equity 2023: € 442,932 ▼ 3% vs 2022 (€ 455,228) Unfavourable step	€ 409,603 Equity 2024: € 409,603 ▼ 8% vs 2023 (€ 442,932) Unfavourable step	€ 493,495 Equity 2025: € 493,495 ▲ 20% vs 2024 (€ 409,603) Favourable step	▲ 20%
Total debts	€ 105,154 Total debts 2022: € 105,154 First fiscal year in the series	€ 100,452 Total debts 2023: € 100,452 ▼ 4% vs 2022 (€ 105,154) Favourable step	€ 113,798 Total debts 2024: € 113,798 ▲ 13% vs 2023 (€ 100,452) Unfavourable step	€ 126,757 Total debts 2025: € 126,757 ▲ 11% vs 2024 (€ 113,798) Unfavourable step	▲ 11%
Land & buildings	€ 557,000 Land & buildings 2022: € 557,000 First fiscal year in the series	€ 540,165 Land & buildings 2023: € 540,165 ▼ 3% vs 2022 (€ 557,000) Unchanged	€ 523,330 Land & buildings 2024: € 523,330 ▼ 3% vs 2023 (€ 540,165) Unchanged	-
Retained profit	€ 435,228 Retained profit 2022: € 435,228 First fiscal year in the series	€ 422,932 Retained profit 2023: € 422,932 ▼ 3% vs 2022 (€ 435,228) Unfavourable step	€ 389,603 Retained profit 2024: € 389,603 ▼ 8% vs 2023 (€ 422,932) Unfavourable step	€ 473,495 Retained profit 2025: € 473,495 ▲ 22% vs 2024 (€ 389,603) Favourable step	▲ 22%
Balance sheet total	€ 560,382 Balance sheet total 2022: € 560,382 First fiscal year in the series	€ 543,385 Balance sheet total 2023: € 543,385 ▼ 3% vs 2022 (€ 560,382) Unchanged	€ 523,401 Balance sheet total 2024: € 523,401 ▼ 4% vs 2023 (€ 543,385) Unchanged	€ 620,252 Balance sheet total 2025: € 620,252 ▲ 19% vs 2024 (€ 523,401) Unchanged	▲ 19%

Key figures of MEDECINE DU SOMMEIL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDECINE DU SOMMEIL?

What happened at MEDECINE DU SOMMEIL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

MEDECINE DU SOMMEIL is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

May 13, 2026 New annual accounts for financial year 2025: profit of € 83,892. Source: NBB ↗
2022 Claude KATZ became a director. NBB
Mar 23, 2000 Start of the company according to the CBE. KBO

In short

From € 19,447 loss in 2022 to € 83,892 profit in 2025.

Paid € 8,389 in corporate taxes since 2022.

Best year ever: 2025, with € 83,892 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MEDECINE DU SOMMEIL? We notify you, reason included.

Follow MEDECINE DU SOMMEIL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit